Proto Labs Inc Financials
Proto Labs Inc (PRLB) reported $533.1M in revenue for fiscal year 2025, up 6.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Proto Labs runs a cash-generative, low-capex manufacturing model supported by steady gross margins and a debt-light balance sheet.
FY2022's reported loss looks more like an accounting shock than a breakdown in the core engine: revenue still sat near$488M while gross margin stayed around44.0% . At the same time, operating cash flow stayed positive at$62.1M even as net income fell to-$103.5M , and the return to profitability in FY2023-FY2025 shows cash generation was far steadier than reported earnings.
In FY2025, free cash flow of
FY2025 ended with
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Proto Labs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Proto Labs Inc has an operating margin of 4.7%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is up from 4.0% the prior year.
Proto Labs Inc's revenue grew 6.4% year-over-year to $533.1M, a solid pace of expansion. This earns a growth score of 42/100.
Proto Labs Inc carries a low D/E ratio of 0.13, meaning only $0.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.49, Proto Labs Inc holds $3.49 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.
Proto Labs Inc converts 11.2% of revenue into free cash flow ($59.7M). This strong cash generation earns a score of 71/100.
Proto Labs Inc's ROE of 3.1% shows moderate profitability relative to equity, earning a score of 33/100. This is up from 2.5% the prior year.
Proto Labs Inc scores 14.15, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.9B) relative to total liabilities ($89.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Proto Labs Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Proto Labs Inc generates $3.51 in operating cash flow ($74.5M OCF vs $21.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Proto Labs Inc generated $533.1M in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.
Proto Labs Inc's EBITDA was $58.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.8% from the prior year.
Proto Labs Inc reported $21.2M in net income in fiscal year 2025. This represents an increase of 28.0% from the prior year.
Proto Labs Inc earned $0.88 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.3% from the prior year.
Cash & Balance Sheet
Proto Labs Inc generated $59.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 13.1% from the prior year.
Proto Labs Inc held $110.8M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Proto Labs Inc's gross margin was 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.1 percentage points from the prior year.
Proto Labs Inc's operating margin was 4.7% in fiscal year 2025, reflecting core business profitability. This is up 0.7 percentage points from the prior year.
Proto Labs Inc's net profit margin was 4.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.7 percentage points from the prior year.
Proto Labs Inc's ROE was 3.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the prior year.
Capital Allocation
Proto Labs Inc invested $42.8M in research and development in fiscal year 2025. This represents an increase of 3.7% from the prior year.
Proto Labs Inc spent $43.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 28.7% from the prior year.
Proto Labs Inc invested $14.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 61.9% from the prior year.
PRLB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $560.5M | $533.1M+6.4% | $500.9M-0.6% | $503.9M+3.2% | $488.4M+0.1% | $488.1M+12.4% | $434.4M-5.3% | $458.7M+2.9% | $445.6M+29.3% | $344.5M+15.6% | $298.1M+12.9% | $264.1M+26.0% | $209.6M+28.5% | $163.1M+29.5% | $126.0M+27.3% | $98.9M |
| Cost of Revenue | $305.9M | $296.0M+6.6% | $277.7M-1.5% | $281.9M+3.3% | $272.9M+2.8% | $265.4M+22.6% | $216.6M-3.1% | $223.4M+8.0% | $206.9M+37.4% | $150.6M+14.9% | $131.1M+19.5% | $109.7M+35.1% | $81.2M+32.2% | $61.4M+23.2% | $49.9M+26.8% | $39.3M |
| Gross Profit | $254.6M | $237.1M+6.2% | $223.2M+0.5% | $222.0M+3.0% | $215.5M-3.2% | $222.7M+2.2% | $217.8M-7.4% | $235.3M-1.4% | $238.7M+23.1% | $193.8M+16.1% | $166.9M+8.1% | $154.4M+20.3% | $128.4M+26.3% | $101.7M+33.6% | $76.1M+27.7% | $59.6M |
| R&D Expenses | $42.4M | $42.8M+3.7% | $41.3M+2.9% | $40.1M+5.0% | $38.2M-13.6% | $44.2M+19.8% | $36.9M+13.0% | $32.7M+13.8% | $28.7M+22.0% | $23.6M+5.2% | $22.4M+22.0% | $18.4M+10.5% | $16.6M+40.0% | $11.9M+29.8% | $9.1M+75.0% | $5.2M |
| SG&A Expenses | $70.9M | $69.8M+8.5% | $64.3M-2.2% | $65.8M-2.6% | $67.5M+20.8% | $55.9M+8.1% | $51.7M+4.0% | $49.8M-5.2% | $52.5M+27.5% | $41.2M+12.4% | $36.7M+23.3% | $29.7M+34.3% | $22.1M+36.9% | $16.2M+15.7% | $14.0M+18.6% | $11.8M |
| Operating Income | $36.8M | $25.1M+26.1% | $19.9M-29.3% | $28.2M+128.7% | -$98.0M-342.9% | $40.3M-32.6% | $59.8M-25.1% | $79.9M-10.2% | $88.9M+23.1% | $72.2M+16.9% | $61.8M-8.0% | $67.1M+10.9% | $60.5M+18.0% | $51.3M+46.8% | $34.9M+30.1% | $26.9M |
| Income Tax | $11.8M | $9.8M+21.6% | $8.1M-24.7% | $10.7M+92.2% | $5.6M-18.0% | $6.8M-43.6% | $12.1M-31.1% | $17.5M+16.4% | $15.1M-33.5% | $22.7M+5.3% | $21.5M+0.8% | $21.3M+13.0% | $18.9M+15.9% | $16.3M+48.9% | $10.9M+24.6% | $8.8M |
| Net Income | $30.5M | $21.2M+28.0% | $16.6M-3.6% | $17.2M+116.6% | -$103.5M-410.0% | $33.4M-34.4% | $50.9M-20.1% | $63.7M-16.9% | $76.6M+47.9% | $51.8M+21.2% | $42.7M-8.2% | $46.5M+11.7% | $41.6M+18.0% | $35.3M+46.8% | $24.0M+33.7% | $18.0M |
| EPS (Diluted) | — | $0.88+33.3% | $0.660.0% | $0.66+117.5% | -$3.77-411.6% | $1.21-36.0% | $1.89-19.6% | $2.35-16.4% | $2.81+45.6% | $1.93+19.9% | $1.61-9.0% | $1.77+10.6% | $1.60+17.6% | $1.36+38.8% | $0.98 | $0.67 |
Not reported in any period shown, so not listed: Interest Expense.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PRLB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $763.4M+2.7% | $743.5M-3.7% | $772.4M-3.7% | $802.2M-13.6% | $928.6M+24.8% | $744.2M+10.5% | $673.7M+8.8% | $619.0M+19.3% | $518.7M+25.2% | $414.2M+14.7% | $361.0M+25.8% | $287.0M+24.7% | $230.2M+33.3% | $172.7M+177.1% | $62.3M |
| Current Assets | $233.5M+19.9% | $194.9M-2.9% | $200.7M+7.6% | $186.6M+1.7% | $183.5M-24.2% | $242.0M+2.4% | $236.4M+9.8% | $215.4M+30.5% | $165.0M+4.6% | $157.8M+14.3% | $138.0M+27.9% | $107.9M-1.8% | $109.8M+21.8% | $90.2M+221.1% | $28.1M |
| Cash & Equivalents | $110.8M+24.4% | $89.1M+6.3% | $83.8M+48.1% | $56.6M-14.2% | $65.9M-48.3% | $127.6M+1.9% | $125.2M+47.2% | $85.0M+131.7% | $36.7M-46.6% | $68.8M+44.4% | $47.7M+10.0% | $43.3M+0.7% | $43.0M+17.1% | $36.8M+351.9% | $8.1M |
| Inventory | $14.4M+17.0% | $12.3M-9.9% | $13.7M+0.6% | $13.6M+3.2% | $13.2M+21.2% | $10.9M+7.8% | $10.1M-0.1% | $10.1M-10.5% | $11.3M+21.1% | $9.3M-4.7% | $9.8M+57.7% | $6.2M+19.9% | $5.2M+11.8% | $4.6M+21.6% | $3.8M |
| Accounts Receivable | $79.0M+18.7% | $66.5M-8.7% | $72.8M-4.4% | $76.2M-4.8% | $80.1M+38.3% | $57.9M+0.7% | $57.5M-2.9% | $59.2M+14.9% | $51.5M+51.2% | $34.1M-5.7% | $36.1M+49.1% | $24.2M+32.2% | $18.3M+16.0% | $15.8M+36.9% | $11.5M |
| Goodwill | $274.0M0.0% | $274.0M0.0% | $274.0M0.0% | $274.0M-31.6% | $400.6M+211.1% | $128.8M0.0% | $128.8M0.0% | $128.8M+0.2% | $128.5M+344.4% | $28.9M0.0% | $28.9M0.0% | $28.9M | $0 | N/A | N/A |
| Total Liabilities | $89.5M+22.0% | $73.4M-4.8% | $77.1M-26.3% | $104.5M+4.4% | $100.1M+0.2% | $99.8M+13.6% | $87.9M+13.4% | $77.5M+34.7% | $57.5M+67.2% | $34.4M+3.0% | $33.4M+55.4% | $21.5M+16.0% | $18.5M+15.7% | $16.0M-80.6% | $82.6M |
| Current Liabilities | $67.0M+25.8% | $53.3M+7.2% | $49.7M-30.6% | $71.6M+30.4% | $54.9M+9.2% | $50.3M+5.6% | $47.6M-9.8% | $52.7M+20.5% | $43.8M+86.8% | $23.4M-10.8% | $26.3M+40.0% | $18.8M+37.3% | $13.7M+18.4% | $11.5M+16.1% | $9.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $10K-93.7% | $159K-55.3% | $356K-41.9% | $613K |
| Total Equity | $673.9M+0.6% | $670.2M-3.6% | $695.3M-0.3% | $697.6M-15.8% | $828.5M+28.6% | $644.4M+10.0% | $585.8M+8.2% | $541.5M+17.4% | $461.2M+21.4% | $379.8M+15.9% | $327.6M+23.4% | $265.5M+25.5% | $211.6M+35.1% | $156.7M+874.1% | -$20.2M |
| Retained Earnings | $240.8M-1.5% | $244.4M-4.7% | $256.4M-0.7% | $258.2M-31.5% | $376.7M+3.8% | $362.9M+11.8% | $324.7M+11.4% | $291.5M+29.7% | $224.7M+27.2% | $176.7M+31.9% | $134.0M+53.2% | $87.5M+90.8% | $45.8M+333.7% | $10.6M+138.1% | -$27.7M |
PRLB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $78.5M | $74.5M-4.3% | $77.8M+6.2% | $73.3M+18.0% | $62.1M+12.4% | $55.2M-48.4% | $107.0M-7.8% | $116.1M-5.6% | $122.9M+50.4% | $81.7M+5.5% | $77.5M+20.9% | $64.1M+12.0% | $57.2M+18.1% | $48.4M+91.4% | $25.3M+7.5% | $23.5M |
| Capital Expenditures | $21.9M | $14.8M+61.9% | $9.2M-67.4% | $28.1M+29.7% | $21.7M-36.6% | $34.2M-27.2% | $47.0M-24.5% | $62.2M-28.6% | $87.1M+166.9% | $32.6M-2.9% | $33.6M-24.2% | $44.4M+2.0% | $43.5M+132.0% | $18.8M+7.8% | $17.4M-8.5% | $19.0M |
| Free Cash Flow | $56.7M | $59.7M-13.1% | $68.7M+52.0% | $45.2M+11.8% | $40.4M+92.0% | $21.0M-64.9% | $60.0M+11.4% | $53.8M+50.2% | $35.8M-27.1% | $49.1M+11.9% | $43.9M+122.4% | $19.7M+44.0% | $13.7M-53.8% | $29.7M+275.4% | $7.9M+74.5% | $4.5M |
| Investing Cash Flow | -$21.8M | -$13.4M+1.3% | -$13.6M-198.3% | -$4.6M+89.4% | -$43.1M+54.5% | -$94.7M+0.8% | -$95.5M-115.5% | -$44.3M+30.0% | -$63.3M+49.0% | -$124.0M-104.1% | -$60.8M+4.5% | -$63.6M | N/A | N/A | -$79.2M-328.3% | -$18.5M |
| Financing Cash Flow | -$19.1M | -$40.4M+31.1% | -$58.5M-39.9% | -$41.9M-49.9% | -$27.9M-25.8% | -$22.2M-107.0% | -$10.7M+66.1% | -$31.6M-202.9% | -$10.4M-213.6% | $9.2M+72.9% | $5.3M+13.1% | $4.7M | N/A | N/A | $82.8M+3009.9% | -$2.8M |
| Share Buybacks | $24.0M | $43.0M-28.7% | $60.3M+37.1% | $44.0M+48.2% | $29.7M+27.4% | $23.3M+58.5% | $14.7M-56.2% | $33.5M+174.1% | $12.2M+177.3% | $4.4M | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
PRLB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5%-0.1pp | 44.6%+0.5pp | 44.1%-0.1pp | 44.1%-1.5pp | 45.6%-4.5pp | 50.1%-1.2pp | 51.3%-2.3pp | 53.6%-2.7pp | 56.3%+0.3pp | 56.0%-2.4pp | 58.5%-2.8pp | 61.3%-1.1pp | 62.4%+1.9pp | 60.4%+0.2pp | 60.3% |
| Operating Margin | 4.7%+0.7pp | 4.0%-1.6pp | 5.6%+25.7pp | -20.1%-28.3pp | 8.3%-5.5pp | 13.8%-3.6pp | 17.4%-2.5pp | 20.0%-1.0pp | 21.0%+0.3pp | 20.7%-4.7pp | 25.4%-3.4pp | 28.9%-2.6pp | 31.4%+3.7pp | 27.7%+0.6pp | 27.2% |
| Net Margin | 4.0%+0.7pp | 3.3%-0.1pp | 3.4%+24.6pp | -21.2%-28.0pp | 6.8%-4.9pp | 11.7%-2.2pp | 13.9%-3.3pp | 17.2%+2.2pp | 15.0%+0.7pp | 14.3%-3.3pp | 17.6%-2.3pp | 19.9%-1.8pp | 21.6%+2.6pp | 19.1%+0.9pp | 18.2% |
| Return on Equity | 3.1%+0.7pp | 2.5%0.0pp | 2.5%+17.3pp | -14.8%-18.9pp | 4.0%-3.9pp | 7.9%-3.0pp | 10.9%-3.3pp | 14.1%+2.9pp | 11.2%0.0pp | 11.2%-3.0pp | 14.2%-1.5pp | 15.7%-1.0pp | 16.7%+1.3pp | 15.3% | N/A |
| Return on Assets | 2.8%+0.5pp | 2.2%0.0pp | 2.2%+15.1pp | -12.9%-16.5pp | 3.6%-3.3pp | 6.8%-2.6pp | 9.4%-2.9pp | 12.4%+2.4pp | 10.0%-0.3pp | 10.3%-2.6pp | 12.9%-1.6pp | 14.5%-0.8pp | 15.3%+1.4pp | 13.9%-14.9pp | 28.8% |
| Current Ratio | 3.49-0.2x | 3.66-0.4x | 4.04+1.4x | 2.61-0.7x | 3.34-1.5x | 4.82-0.2x | 4.97+0.9x | 4.08+0.3x | 3.77-3.0x | 6.74+1.5x | 5.25-0.5x | 5.75-2.3x | 8.04+0.2x | 7.81+5.0x | 2.82 |
| Debt-to-Equity | 0.130.0x | 0.110.0x | 0.110.0x | 0.150.0x | 0.120.0x | 0.150.0x | 0.150.0x | 0.140.0x | 0.120.0x | 0.090.0x | 0.10+0.1x | 0.000.0x | 0.000.0x | 0.00 | N/A |
| FCF Margin | 11.2%-2.5pp | 13.7%+4.8pp | 9.0%+0.7pp | 8.3%+4.0pp | 4.3%-9.5pp | 13.8%+2.1pp | 11.7%+3.7pp | 8.0%-6.2pp | 14.3%-0.5pp | 14.7%+7.2pp | 7.5%+0.9pp | 6.5%-11.7pp | 18.2%+11.9pp | 6.3%+1.7pp | 4.6% |
Similar Companies
Where Proto Labs Inc Ranks
Frequently Asked Questions
What is Proto Labs Inc's annual revenue?
Proto Labs Inc (PRLB) reported $533.1M in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Proto Labs Inc's revenue growing?
Proto Labs Inc (PRLB) revenue grew by 6.4% year-over-year, from $500.9M to $533.1M in fiscal year 2025.
Is Proto Labs Inc profitable?
Yes, Proto Labs Inc (PRLB) reported a net income of $21.2M in fiscal year 2025, with a net profit margin of 4.0%.
What is Proto Labs Inc's EBITDA?
Proto Labs Inc (PRLB) had EBITDA of $58.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Proto Labs Inc's gross margin?
Proto Labs Inc (PRLB) had a gross margin of 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Proto Labs Inc's operating margin?
Proto Labs Inc (PRLB) had an operating margin of 4.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Proto Labs Inc's net profit margin?
Proto Labs Inc (PRLB) had a net profit margin of 4.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Proto Labs Inc's return on equity (ROE)?
Proto Labs Inc (PRLB) has a return on equity of 3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Proto Labs Inc's free cash flow?
Proto Labs Inc (PRLB) generated $59.7M in free cash flow during fiscal year 2025. This represents a -13.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Proto Labs Inc's operating cash flow?
Proto Labs Inc (PRLB) generated $74.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Proto Labs Inc's total assets?
Proto Labs Inc (PRLB) had $763.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Proto Labs Inc's capital expenditures?
Proto Labs Inc (PRLB) invested $14.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Proto Labs Inc spend on research and development?
Proto Labs Inc (PRLB) invested $42.8M in research and development during fiscal year 2025.
What is Proto Labs Inc's current ratio?
Proto Labs Inc (PRLB) had a current ratio of 3.49 as of fiscal year 2025, which is generally considered healthy.
What is Proto Labs Inc's debt-to-equity ratio?
Proto Labs Inc (PRLB) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Proto Labs Inc's return on assets (ROA)?
Proto Labs Inc (PRLB) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Proto Labs Inc's Altman Z-Score?
Proto Labs Inc (PRLB) has an Altman Z-Score of 14.15, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Proto Labs Inc's Piotroski F-Score?
Proto Labs Inc (PRLB) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Proto Labs Inc's earnings high quality?
Proto Labs Inc (PRLB) has an earnings quality ratio of 3.51x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Proto Labs Inc?
Proto Labs Inc (PRLB) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.